SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition
SEC Accession No. 0001193125-17-125987
Filing Date
2017-04-17
Accepted
2017-04-17 16:09:27
Documents
3
Period of Report
2017-04-17
Filing Date Changed
2017-04-17

Document Format Files

Seq Description Document Type Size
1 PREM14A d320129dprem14a.htm PREM14A 3478522
2 GRAPHIC g320129g79h75.jpg GRAPHIC 35710
3 GRAPHIC g320129g80k56.jpg GRAPHIC 33036
  Complete submission text file 0001193125-17-125987.txt   3574452
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-36395 | Film No.: 17764659
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1